195 results on '"Tesson, Bruno"'
Search Results
2. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
3. Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma
4. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL
5. Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles
6. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma
7. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
8. Optical Genome Mapping Provides New Molecular Insights in High-Risk Mantle Cell Lymphoma: A Lysa Study
9. Human germinal center transcriptional programs are de-synchronized in B cell lymphoma
10. P1166: BRIGATINIB IN PATIENTS WITH ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA WHO HAVE FAILED BRENTUXIMAB VEDOTIN
11. Long‐term follow‐up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T‐cells in follicular lymphoma patients treated by rituximab‐maintenance regimen
12. Supplementary Data from Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
13. Table S5. Cohort variants. from Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
14. Table S2. Cell of origin according to MYD88 mutations. from Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
15. Table S7. Immunohistochemical markers and gene rearrangements according to MYD88 variants. from Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
16. Table S10. Clinical characteristics of patients with CNS relapse. from Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
17. Table S1. Clinical and immunohistochemical data according to MYD88 mutation status. from Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
18. Table S6. Cohort copy number variations. from Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
19. Supplementary Figures from Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
20. Supplementary Figure 1 from Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
21. Supplementary Methods from Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
22. Data from Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
23. Supplementary Figure Legend from Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
24. Exploring the genetic landscape of HCV-related B-cell lymphomas using whole exome sequencing
25. TIPIN depletion leads to apoptosis in breast cancer cells
26. Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma
27. Analyse fonctionnelle des anomalies de la moésine dans les lymphomes NK/T
28. Patient-derived xenografts recapitulate molecular features of human uveal melanomas
29. Réussir comme dirigeant.e : Construire son action - Oser être soi
30. Réussir comme dirigeant.e : Construire son action - Oser être soi
31. Critical reasoning on causal inference in genome-wide linkage and association studies
32. Defining gene and QTL networks
33. Single-Cell and Spatial Analyses Characterize Distinct Subsets of Malignant T Cells in Angioimmunoblastic T Cell Lymphoma
34. High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B
35. Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies
36. eQTL Analysis in Mice and Rats
37. Oncogenetic landscape of lymphomagenesis in coeliac disease
38. High Dimensional Tissue-Based Spatial Analysis of the Tumor Microenvironment of Follicular Lymphoma Reveals Unique Immune Niches inside Malignant Follicles
39. Oncogenetic Landscape Of Lymphomagenesis In Coeliac Disease
40. Prognostic relevance of CD4+ T-cells in the microenvironment of newly diagnosed follicular lymphoma (FL) patients is independent of the tumor gene expression profile.
41. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
42. DiffCoEx: a simple and sensitive method to find differentially coexpressed gene modules
43. Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes
44. Oncogenetic landscape of lymphomagenesis in coeliac disease
45. Predictive gene-expression score for follicular lymphoma – Authors' reply
46. LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers
47. Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P–Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
48. BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab
49. The Wnt3a targetome in triple-negative breast cancer cell lines
50. Genetical genomics approaches for systems genetics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.